Singapore Paincare's (SGX:FRQ) attributable profit for the six months ended Dec. 31, 2024, declined 53% to SG$453,000 from SG$969,000 a year earlier, according to a Friday filing with the Singapore Exchange.
Earnings per share dropped to SG$0.0026 compared with SG$0.0057 in the comparable period.
Revenue was up 2.8% year over year to SG$13.7 million from SG$13.4 million, driven by increased revenue from specialist clinics.
Shares of the health and medical treatment company were down over 3% in recent trading.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.